TARDBP and amyotrophic lateral sclerosis: An initial study of TARDBP-ALS iPSC-derived motor neurons (carrying S393L and G294V mutations) showed reduced survival but no change in γH2AX, suggesting DNA damage was not a feature of TARDBP-ALS [116].